Based on the Numinus Wellness Inc stock forecast from 0 analysts, the average analyst target price for Numinus Wellness Inc is not available over the next 12 months. Numinus Wellness Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Numinus Wellness Inc is Bearish, which is based on 2 positive signals and 8 negative signals. At the last closing, Numinus Wellness Inc’s stock price was CAD 0.04. Numinus Wellness Inc’s stock price has changed by +0.00% over the past week, -27.27% over the past month and -66.67% over the last year.
No recent analyst target price found for Numinus Wellness Inc
No recent average analyst rating found for Numinus Wellness Inc
Company Overview Numinus Wellness Inc
Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada. Read Less
Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment o...Read More
Frequently Asked Questions About Numinus Wellness Inc (NUMI:CA) Stock
Stock Target Advisor's fundamental analysis for Numinus Wellness Inc's stock is Bearish.
Unfortunately we do not have enough data on NUMI:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on NUMI:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on NUMI:CA's stock to indicate if its overvalued.
The last closing price of NUMI:CA's stock was CAD 0.04.
The most recent market capitalization for NUMI:CA is CAD 0.01B.
Unfortunately we do not have enough analyst data on NUMI:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Numinus Wellness Inc's stock.
As per our most recent records Numinus Wellness Inc has 0 Employees.
Numinus Wellness Inc's registered address is 666 Burrard Street, Vancouver, BC, Canada, V6C 2X8.
You can get more information about it from Numinus Wellness Inc's website at https://www.numinus.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Numinus Wellness Inc (NUMI:CA) Stock
Stock Target Advisor's fundamental analysis for Numinus Wellness Inc's stock is Bearish.
Unfortunately we do not have enough data on NUMI:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on NUMI:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on NUMI:CA's stock to indicate if its overvalued.
The last closing price of NUMI:CA's stock was CAD 0.04.
The most recent market capitalization for NUMI:CA is CAD 0.01B.
Unfortunately we do not have enough analyst data on NUMI:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Numinus Wellness Inc's stock.
As per our most recent records Numinus Wellness Inc has 0 Employees.
Numinus Wellness Inc's registered address is 666 Burrard Street, Vancouver, BC, Canada, V6C 2X8.
You can get more information about it from Numinus Wellness Inc's website at https://www.numinus.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NUMI:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
